These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36847559)

  • 21.
    Boyanova L
    Future Microbiol; 2023 Mar; 18():235-244. PubMed ID: 37042433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Draft genome sequences of three multidrug-resistant Cutibacterium (formerly Propionibacterium) acnes strains isolated from acne patients, China.
    Zhang N; Lu Z; Ma Y
    J Glob Antimicrob Resist; 2017 Dec; 11():114-115. PubMed ID: 29051020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility profiles of Propionibacterium acnes isolated from patients with acne vulgaris.
    Grech I
    J Glob Antimicrob Resist; 2014 Mar; 2(1):35-38. PubMed ID: 27873635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne.
    Mercieca L; Mangion J; Cefai J; Bezzina T; Schwaiger C; Micallef D; Corso R; Scerri L; Boffa MJ; Caruana P; Clark E; Aquilina S
    J Clin Aesthet Dermatol; 2020 Jun; 13(6):11-16. PubMed ID: 32884613
    [No Abstract]   [Full Text] [Related]  

  • 28.
    Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
    Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial Susceptibility Testing of
    Skadins I; Zavorins A; Kroica J; Pavloviča T; Bruzgule D; Averjanova T
    Clin Cosmet Investig Dermatol; 2021; 14():671-677. PubMed ID: 34168479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avidumicin, a novel cyclic bacteriocin, produced by Cutibacterium avidum shows anti-Cutibacterium acnes activity.
    Koizumi J; Nakase K; Noguchi N; Nakaminami H
    J Antibiot (Tokyo); 2023 Sep; 76(9):511-521. PubMed ID: 37264118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study examining the prevalence of antibiotic-resistant Cutibacterium acnes isolated from patients with acne in Bangkok, Thailand.
    Sermswan P; Sriharat R; Saithong S; Laowansiri M; Amornruk N; Chiewchengchol D; Noppakun N; Asawanonda P; Chatsuwan T; Kumtornrut C
    J Dermatol; 2023 Aug; 50(8):1008-1013. PubMed ID: 37183535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
    Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
    BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
    Nakase K; Okamoto Y; Aoki S; Noguchi N
    J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic determinants of antimicrobial resistance in three multi-drug resistant strains of
    Beirne C; McCann E; McDowell A; Miliotis G
    Access Microbiol; 2022; 4(8):acmi000404. PubMed ID: 36133174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Antimicrobial Susceptibility and Treatment Outcome in Acne Vulgaris Patients: A Pilot Study.
    Yadav AK; Bhooshan S; Johnson A; Asati DP; Nema S; Biswas D
    J Lab Physicians; 2020 Dec; 12(4):233-238. PubMed ID: 33469248
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.